Eduardo completed his PhD studies in October 2018 in collaboration with Prof Matthew Cooper at the Institute for Molecular Biosciences (IMB). He is currently extending his research within the Neuroinflammation Lab at the School of Biomedical Sciences. His research focuses on the pharmacological targeting of the innate immune response during neurodegeneration.